The physician and his practice also had to sign into a “multi-year integrity agreement” that includes specific training and reporting requirements.

Two different companies announced that they are recalling all lots of the medication. 

The funding includes $8.5 billion in American Rescue Plan resources for providers who treat Medicaid, Children's Health Insurance Program and Medicare patients.

A new analysis in the American Journal of Preventive Medicine examined the association between nearby violent crimes and a person's blood pressure.

CardioSmart, an online resource for both patients and clinicians, has a new editor. 

The new analysis, published in Blood Advances, examined the impact of hydroxyurea treatment among children and young adults.

Expanded FDA labeling for sacubitril/valsartan could make a massive impact on patient care in the next three years.

AI and machine learning are adept at selecting good candidates for total joint arthroplasty and predicting which patients will and won’t experience post-op complications.